Scientists test cannabis as weapon against deadly brain tumor
NCT ID NCT03529448
Summary
This study tested whether adding two cannabis compounds (THC and CBD) to the standard treatment for glioblastoma, a very aggressive brain cancer, is safe and might help control the disease. Researchers worked with 33 adults newly diagnosed with this cancer to find the highest safe dose of the cannabis combination. The goal was to see if this new approach could improve outcomes for a disease where survival rates have not improved much in the last decade.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Complejo Hospitalario Regional Virgen de las Nieves
Granada, 18004, Spain
-
Hospital Clínico Universitario de Salamanca
Salamanca, 37007, Spain
-
Hospital Regional Universitario de Malaga
Málaga, Spain
-
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
-
Hospital Universitario Son Espases
Palma de Mallorca, Mallorca, Spain
-
Hospital Universitario Virgen del Rocío
Seville, Andalusia, 41013, Spain
-
Hospital del Mar
Barcelona, 08003, Spain
-
Institut Català d'Oncología L'Hospitalet
L'Hospitalet de Llobregat, Barcelona, 08908, Spain
Conditions
Explore the condition pages connected to this study.